... first presented at the San Antonio Breast Cancer Symposium in December 2021 ... BriaCell is an immuno-oncology focused biotechnology company ...
News
- BriaCell Receives FDA Fast Track Approval for Targeted Breast Cancer Immunotherapy
- Scripps Health and UT Health San Antonio purchase Oncora's software to improve ... - Benzinga
PHILADELPHIA, April 13, 2022 /PRNewswire/ -- Oncora Medical (Oncora) announced today that Scripps Health (Scripps) and UT Health San Antonio (UT ...
- Scripps Health and UT Health San Antonio purchase Oncora's software to improve ...
Oncolytics Biotech® Inc. (NASDAQ: ONCY) (TSX: ONC) today announced that Thomas Heineman, M.D., Ph.D., the Company's Chief Medical Officer, will ...
- Alamo City in contention for national medical research headquarters - San Antonio Business Journal
The federal agency would be tasked with improving Washington's ability to expedite biomedical and health research, and the development of its ...
- mRNA Quality Control: Root Cause of Tau-Induced Neurodegeneration in Alzheimer's and ...
... jointly by the Joe R. and Teresa Lozano Long School of Medicine and the Graduate School of Biomedical Sciences of UT Health San Antonio.